Efficacy and Safety of GTx-024 in Patients With Estrogen Receptor (ER)+/Androgen Receptor (AR)+ Breast Cancer

Clinical trial NCT02463032 · COMPLETED

Trial details

NCT number: NCT02463032
Sponsor: GTx
Status: COMPLETED
Phase: Phase 2
Study type: INTERVENTIONAL

ER+ and AR+ Breast Cancer

Start date: 2015-08-01
Primary completion: 2019-03-01
Enrollment: 136

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.